EVLO
EVELO BIOSCIENCES INC
stockOTC
evelo biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines – monoclonal microbials. monoclonal microbials are orally delivered medicines that modulate systemic immunology and biology through direct interactions with human cells in the gut. these new medicines are broadly applicable across many diseases – including autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory diseases and cancer. monoclonal microbials have the potential to fundamentally change traditional models of drug discovery and development. by finding and selecting naturally occurring monoclonal microbials with defined therapeutic effects, evelo can improve the speed, cost and success of drug discovery and development. evelo's platform enables pharmacological intervention at all stages of disease with naturally occurring, safe and effective monoclonal microbials. evelo biosciences was conceived and created within venturelabs®, flag
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1M | 0.00 | 2026-09-02 | +19900.00% | 150313.146 |
| 3M | 0.00 | 2026-07-07 | +19900.00% | -4035.815 |
| 6M | 0.00 | 2026-04-09 | +100.00% | -1953.012 |
| 1Y | 0.00 | 2025-10-06 | -60.00% | -256.666 |
| 2Y | 0.00 | 2024-10-04 | +100.00% | — |
| 5Y | 135.60 | 2021-10-06 | -100.00% | 8.782 |
EVELO BIOSCIENCES INC (OTC:EVLO) stock price today is $0.00, and today's volume is 166,718. EVLO is up 100.000% today. The 30 day average volume is 7,181. EVLO market cap is $3,797 with 18.98M shares outstanding.